Raysearch Laboratories Ab recalls RayCare 2024A SP4. Oncology Information Systems.
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Beam set delivery note issues in which there is potential data loss if the beam set delivery note is modified simultaneously and/or if a note is updated during a treatment session, the user is not notified of the change.
- Products
-
- RayCare 2024A SP4. Oncology Information Systems.
- Company
- Raysearch Laboratories Ab
- Where it was sold
-
Worldwide - US Nationwide distribution.
Nationwide
- Units affected
- 3 units
- About this recall
- RayCare 2024A SP4. Oncology Information Systems.